Mary Maas

501 total citations
12 papers, 386 citations indexed

About

Mary Maas is a scholar working on Immunology, Oncology and Epidemiology. According to data from OpenAlex, Mary Maas has authored 12 papers receiving a total of 386 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Immunology, 5 papers in Oncology and 3 papers in Epidemiology. Recurrent topics in Mary Maas's work include Immunotherapy and Immune Responses (5 papers), Immune Cell Function and Interaction (5 papers) and Immune cells in cancer (4 papers). Mary Maas is often cited by papers focused on Immunotherapy and Immune Responses (5 papers), Immune Cell Function and Interaction (5 papers) and Immune cells in cancer (4 papers). Mary Maas collaborates with scholars based in United States and United Kingdom. Mary Maas's co-authors include Allan B. Dietz, Dennis A. Gastineau, Michael P. Gustafson, Yi Lin, Virginia P. Van Keulen, Greg W. Butler, Tobias Peikert, Patrick B. Johnston, Svetlana Bornschlegl and Anthony J. Windebank and has published in prestigious journals such as Blood, PLoS ONE and British Journal of Haematology.

In The Last Decade

Mary Maas

12 papers receiving 382 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mary Maas United States	8	215	122	106	102	60	12	386
Narges Seyfizadeh Iran	12	190 0.9×	97 0.8×	69 0.7×	156 1.5×	12 0.2×	20	474
Mihoko Shibuya Japan	10	233 1.1×	110 0.9×	26 0.2×	82 0.8×	24 0.4×	15	494
Dawit Aregawi United States	10	130 0.6×	95 0.8×	165 1.6×	217 2.1×	40 0.7×	31	588
Ji-Ming Wang China	9	81 0.4×	80 0.7×	131 1.2×	136 1.3×	36 0.6×	16	368
Ludovic Belle Belgium	11	200 0.9×	94 0.8×	101 1.0×	50 0.5×	18 0.3×	18	385
Adipong Brickshawana United States	6	175 0.8×	102 0.8×	35 0.3×	120 1.2×	56 0.9×	7	427
Jaris Valencia Spain	16	242 1.1×	121 1.0×	114 1.1×	285 2.8×	7 0.1×	25	601
Sabine Wintterle Germany	6	217 1.0×	220 1.8×	84 0.8×	42 0.4×	10 0.2×	7	393
Zhu Xishan China	5	99 0.5×	60 0.5×	239 2.3×	112 1.1×	13 0.2×	9	350
Yutaka Shimazu Japan	8	110 0.5×	124 1.0×	110 1.0×	321 3.1×	68 1.1×	21	535

Countries citing papers authored by Mary Maas

Since Specialization

Citations

This map shows the geographic impact of Mary Maas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mary Maas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mary Maas more than expected).

Fields of papers citing papers by Mary Maas

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mary Maas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mary Maas. The network helps show where Mary Maas may publish in the future.

Co-authorship network of co-authors of Mary Maas

This figure shows the co-authorship network connecting the top 25 collaborators of Mary Maas. A scholar is included among the top collaborators of Mary Maas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mary Maas. Mary Maas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

Gustafson, Michael P., Nathan P. Staff, Svetlana Bornschlegl, et al.. (2017). Comprehensive immune profiling reveals substantial immune system alterations in a subset of patients with amyotrophic lateral sclerosis. PLoS ONE. 12(7). e0182002–e0182002. 62 indexed citations

Gustafson, Michael P., Yi Lin, Mary Maas, et al.. (2015). A Method for Identification and Analysis of Non-Overlapping Myeloid Immunophenotypes in Humans. PLoS ONE. 10(3). e0121546–e0121546. 88 indexed citations

Hingorani, Pooja, Mary Maas, Michael P. Gustafson, et al.. (2015). Increased CTLA-4+ T cells and an increased ratio of monocytes with loss of class II (CD14+ HLA-DRlo/neg) found in aggressive pediatric sarcoma patients. Journal for ImmunoTherapy of Cancer. 3(1). 35–35. 48 indexed citations

Lin, Yi, Thomas D. Atwell, Adam J. Weisbrod, et al.. (2015). Dendritic cell vaccine treatment for indolent B-cell non-Hodgkin lymphoma: clinical trial in progress. Cytotherapy. 17(6). S17–S17. 2 indexed citations

Atwell, Thomas D., Adam J. Weisbrod, Mary Maas, et al.. (2014). Dendritic Cell Vaccine Treatment for B-Cell Non-Hodgkin Lymphoma: Clinical Trial in Progress. Blood. 124(21). 4474–4474. 3 indexed citations

Gustafson, Michael P., Yi Lin, Mary Maas, Dennis A. Gastineau, & Allan B. Dietz. (2014). A method for non-overlapping identification of human myeloid derived suppressor cells. Journal for ImmunoTherapy of Cancer. 2(S3). 1 indexed citations

Gustafson, Michael P., Yi Lin, Betsy LaPlant, et al.. (2013). Immune monitoring using the predictive power of immune profiles. Journal for ImmunoTherapy of Cancer. 1(1). 7–7. 45 indexed citations

Dietz, Allan B., Michael P. Gustafson, Yi Lin, et al.. (2013). Immune monitoring using the predictive power of immune profiles. Cytotherapy. 15(4). S48–S48. 3 indexed citations

Sassoon, Adam, Yasuhiro Ozasa, Takako Chikenji, et al.. (2012). Skeletal muscle and bone marrow derived stromal cells: A comparison of tenocyte differentiation capabilities. Journal of Orthopaedic Research®. 30(11). 1710–1718. 22 indexed citations

10.

Ding, Wei, Grzegorz S. Nowakowski, Traci R. Knox, et al.. (2009). Bi‐directional activation between mesenchymal stem cells and CLL B‐cells: implication for CLL disease progression. British Journal of Haematology. 147(4). 471–483. 68 indexed citations

11.

Markovic, Svetomir N., Allan B. Dietz, Mary Maas, et al.. (2006). Preparing clinical-grade myeloid dendritic cells by electroporation-mediated transfection of in vitro amplified tumor-derived mRNA and safety testing in stage IV malignant melanoma. Journal of Translational Medicine. 4(1). 35–35. 24 indexed citations

12.

Dietz, Allan B., Douglas Padley, Greg W. Butler, et al.. (2004). Clinical-grade manufacturing of DC from CD14+ precursors: experience from phase I clinical trials in CML and malignant melanoma. Cytotherapy. 6(6). 563–570. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact